Paper41006362
Medicinal potential of Morchella esculenta oil inhibits cancer cell proliferation, metabolite characterization through GCMS, GC×GC-TOF-MS and UHPLC-QTOF-MS.
Chouhan M and 5 others. Sci Rep, 2025. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Medicinal potential of Morchella esculenta oil inhibits cancer cell proliferation, metabolite characterization through GCMS, GC×GC-TOF-MS and UHPLC-QTOF-MS. Papers, record 41006362. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41006362
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Medicinal potential of Morchella esculenta oil inhibits cancer cell proliferation, metabolite characterization through GCMS, GC×GC-TOF-MS and UHPLC-QTOF-MS.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cell Proliferation | Major topic |
| Plant Oils | Major topic |
| Antineoplastic Agents, Phytogenic | Major topic |
| Humans | |
| Antioxidants | |
| Chromatography, High Pressure Liquid | |
| Gas Chromatography-Mass Spectrometry | |
| Flavonoids | |
| Cell Line, Tumor | |
| Phenols | |
| Phytochemicals | |
| MCF-7 Cells |
Source PubMed
References37
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31877271 | Molecular therapy with derivatives of amino benzoic acid inhibits tumor growth and metastasis in murine models of bladder cancer through inhibition of TNFα/NFΚB and iNOS/NO pathways. | Biochem Pharmacol | 2020 | https://conductscience.org/library/papers/31877271 | PubMed |
| 2 | 37637038 | Molecular mechanism of palmitic acid and its derivatives in tumor progression. | Front Oncol | 2023 | https://conductscience.org/library/papers/37637038 | PubMed |
| 3 | 20550954 | Edible mushrooms: role in the prevention of cardiovascular diseases. | Fitoterapia | 2010 | https://conductscience.org/library/papers/20550954 | PubMed |
| 4 | 30978964 | Total Phenolic Content, Flavonoid Content and Antioxidant Potential of Wild Vegetables from Western Nepal. | Plants (Basel) | 2019 | https://conductscience.org/library/papers/30978964 | PubMed |
| 5 | 39362080 | Design and synthesis of novel mitochondria-targeted ergosterol peroxide derivatives as potential anti-cancer agents. | Bioorg Chem | 2024 | https://conductscience.org/library/papers/39362080 | PubMed |
| 6 | 39617788 | A stearate-rich diet and oleate restriction directly inhibit tumor growth via the unfolded protein response. | Exp Mol Med | 2024 | https://conductscience.org/library/papers/39617788 | PubMed |
| 7 | 37482932 | An antimicrobial metabolite n- hexadecenoic acid from marine sponge-associated bacteria Bacillus subtilis effectively inhibited biofilm forming multidrug-resistant P. aeruginosa. | Biofouling | 2023 | https://conductscience.org/library/papers/37482932 | PubMed |
| 8 | 34408877 | New approaches and procedures for cancer treatment: Current perspectives. | SAGE Open Med | 2021 | https://conductscience.org/library/papers/34408877 | PubMed |
| 9 | 23588432 | Antitumor effect of oleic acid; mechanisms of action: a review. | Nutr Hosp | 2012 | https://conductscience.org/library/papers/23588432 | PubMed |
| 10 | 35965565 | The key role of sphingolipid metabolism in cancer: New therapeutic targets, diagnostic and prognostic values, and anti-tumor immunotherapy resistance. | Front Oncol | 2022 | https://conductscience.org/library/papers/35965565 | PubMed |
| 11 | 16611065 | Sphingolipids in anticancer therapy. | Curr Med Chem | 2006 | https://conductscience.org/library/papers/16611065 | PubMed |
| 12 | 38453116 | Extraction, structure and antioxidant activity of the polysaccharides from morels (Morchella spp.): A review. | Int J Biol Macromol | 2024 | https://conductscience.org/library/papers/38453116 | PubMed |
| 13 | 22490569 | Metabolic disorders of fatty acids and fatty acid amides associated with human gastric cancer morbidity. | Chin Med J (Engl) | 2012 | https://conductscience.org/library/papers/22490569 | PubMed |
| 14 | 36551687 | Natural Products/Bioactive Compounds as a Source of Anticancer Drugs. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36551687 | PubMed |
| 15 | 20192845 | Antimicrobial and antioxidant activities of mycelia of 10 wild mushroom species. | J Med Food | 2010 | https://conductscience.org/library/papers/20192845 | PubMed |
| 16 | 21871959 | A comparative study on the effectiveness of cis- and trans-form of cinnamic acid treatments for inhibiting invasive activity of human lung adenocarcinoma cells. | Eur J Pharm Sci | 2011 | https://conductscience.org/library/papers/21871959 | PubMed |
| 17 | 35940783 | Mycochemical profile and health-promoting effects of morel mushroom Morchella esculenta (L.) - A review. | Food Res Int | 2022 | https://conductscience.org/library/papers/35940783 | PubMed |
| 18 | 36094647 | Investigation of Three Morchella Species for Anticancer Activity Against Colon Cancer Cell Lines by UPLC-MS-Based Chemical Analysis. | Appl Biochem Biotechnol | 2023 | https://conductscience.org/library/papers/36094647 | PubMed |
| 19 | 37006947 | Cultivation, nutritional value, bioactive compounds of morels, and their health benefits: A systematic review. | Front Nutr | 2023 | https://conductscience.org/library/papers/37006947 | PubMed |
| 20 | 37956922 | Phytosphingosine inhibits the growth of lung adenocarcinoma cells by inducing G2/M-phase arrest, apoptosis, and mitochondria-dependent pathway cell death in vitro and in vivo. | Chem Biol Interact | 2024 | https://conductscience.org/library/papers/37956922 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42007978 | Exploring Morchella mushrooms: a natural approach to cancer therapy. | Arch Microbiol | 2026 | https://conductscience.org/library/papers/42007978 |
Source PubMed
Genes10
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BAX | 581 | PubTator's text mining | https://conductscience.org/library/genes/581 | NCBI Gene |
| BCL2 | 596 | PubTator's text mining | https://conductscience.org/library/genes/596 | NCBI Gene |
| CASP3 | 836 | PubTator's text mining | https://conductscience.org/library/genes/836 | NCBI Gene |
| CASP7 | 840 | PubTator's text mining | https://conductscience.org/library/genes/840 | NCBI Gene |
| CASP9 | 842 | PubTator's text mining | https://conductscience.org/library/genes/842 | NCBI Gene |
| CDK4 | 1019 | PubTator's text mining | https://conductscience.org/library/genes/1019 | NCBI Gene |
| ISYNA1 | 51477 | PubTator's text mining | https://conductscience.org/library/genes/51477 | NCBI Gene |
| NFKB1 | 4790 | PubTator's text mining | https://conductscience.org/library/genes/4790 | NCBI Gene |
| TNF | 7124 | PubTator's text mining | https://conductscience.org/library/genes/7124 | NCBI Gene |
| TP53 | 7157 | PubTator's text mining | https://conductscience.org/library/genes/7157 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41006362
GET https://conductscience.org/api/papers/v1/41006362/references?page=2